214 related articles for article (PubMed ID: 23251456)
1. Activation of Invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
Horikoshi M; Goto D; Segawa S; Yoshiga Y; Iwanami K; Inoue A; Tanaka Y; Matsumoto I; Sumida T
PLoS One; 2012; 7(12):e51215. PubMed ID: 23251456
[TBL] [Abstract][Full Text] [Related]
2. Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
Yoshiga Y; Goto D; Segawa S; Horikoshi M; Hayashi T; Matsumoto I; Ito S; Taniguchi M; Sumida T
Clin Exp Immunol; 2011 May; 164(2):236-47. PubMed ID: 21391989
[TBL] [Abstract][Full Text] [Related]
3. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner.
Coppieters K; Van Beneden K; Jacques P; Dewint P; Vervloet A; Vander Cruyssen B; Van Calenbergh S; Chen G; Franck RW; Verbruggen G; Deforce D; Matthys P; Tsuji M; Rottiers P; Elewaut D
J Immunol; 2007 Aug; 179(4):2300-9. PubMed ID: 17675491
[TBL] [Abstract][Full Text] [Related]
4. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
[TBL] [Abstract][Full Text] [Related]
5. Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Iwanami K; Matsumoto I; Yoshiga Y; Inoue A; Kondo Y; Yamamoto K; Tanaka Y; Minami R; Hayashi T; Goto D; Ito S; Nishimura Y; Sumida T
Arthritis Res Ther; 2009; 11(6):R167. PubMed ID: 19900268
[TBL] [Abstract][Full Text] [Related]
6. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis.
Matsumoto I; Zhang H; Yasukochi T; Iwanami K; Tanaka Y; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
Arthritis Res Ther; 2008; 10(3):R66. PubMed ID: 18534002
[TBL] [Abstract][Full Text] [Related]
8. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
Iwanami K; Matsumoto I; Tanaka Y; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
Arthritis Res Ther; 2008; 10(6):R130. PubMed ID: 18992137
[TBL] [Abstract][Full Text] [Related]
9. B cells play a crucial role as antigen-presenting cells and collaborate with inflammatory cytokines in glucose-6-phosphate isomerase-induced arthritis.
Tanaka-Watanabe Y; Matsumoto I; Iwanami K; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
Clin Exp Immunol; 2009 Feb; 155(2):285-94. PubMed ID: 19032549
[TBL] [Abstract][Full Text] [Related]
10. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
11. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
12. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of invariant natural killer T cells occur and accelerate brain infarction in permanent ischemic stroke in mice.
Wang ZK; Xue L; Wang T; Wang XJ; Su ZQ
Neurosci Lett; 2016 Oct; 633():62-68. PubMed ID: 27637387
[TBL] [Abstract][Full Text] [Related]
14. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.
Fujii S; Shimizu K; Hemmi H; Fukui M; Bonito AJ; Chen G; Franck RW; Tsuji M; Steinman RM
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11252-7. PubMed ID: 16844772
[TBL] [Abstract][Full Text] [Related]
15. Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells.
Fallarini S; Paoletti T; Panza L; Lombardi G
Biochem Pharmacol; 2008 Sep; 76(6):738-50. PubMed ID: 18671950
[TBL] [Abstract][Full Text] [Related]
16. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
[TBL] [Abstract][Full Text] [Related]
17. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
[TBL] [Abstract][Full Text] [Related]
18. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
19. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107
[TBL] [Abstract][Full Text] [Related]
20. Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.
Sullivan BA; Kronenberg M
J Clin Invest; 2005 Sep; 115(9):2328-9. PubMed ID: 16138189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
